The recent buyout of Idenix Pharmaceuticals (IDIX) by drug maker Merck & Co (MRK) is another high-profile example of the race to scoop up promising biotechnology companies before they hit it big. Drug companies know the pipeline for new products must constantly be refreshed by cutting-edge innovations that can lead to billions in future profits.

The 230% single day gain that IDIX experienced as a result of the buyout had a huge impact on the SPDR Biotechnology ETF (XBI), which rose more than 6% that day. Because XBI is a modified equal weighted index, IDIX had a much larger impact on the total returns than a market-cap weighted fund such as the iShares NASDAQ Biotechnology ETF (IBB).

IDIX previously represented just 1.5% of the underlying holdings in XBI, but the recent jump has catapulted its total weight within the index to 4.5%.

XBI

This acquisition also sparked a strong rally in companies with competitive products such as Achillion Pharmaceuticals (ACHN), which is developing a similar hepatitis C treatment.

The latest round of M&A activity in the biotechnology arena got me thinking about how these buyouts can positively impact ETF indexes in addition to the direct equity holders. From a fundamental perspective, the attractiveness of smaller firms that can be bought out for billions of dollars by heavy-hitters is a win for many niche industry-level ETF participants.

When most indexes are constructed, underlying stocks are added or removed based on their market cap or fundamental merits according to the constraints of the index provider.

In more broad-based equity indices such as the S&P 500 Index (.SPX), each participant is evaluated on a regular basis by a board of trustees. Any stock that is added or removed from the index is usually done so with modest fanfare and little net gain to the overall performance of the group.

However, with more focused groups such as XBI, you have the potential for fireworks when an acquisition is announced. The removal of one stock ultimately paves the way for another company to be added in its place as well. This continual cycle of refreshment can breed further gains within the ETF, assuming the overall uptrend remains intact.

This is why it’s critical to pay attention to index construction when selecting an ETF to add to your portfolio. While there are often times competing products with similar names, the underlying asset allocation or security selection methodology can be radically different. This can lead to significant divergences in total return over time.

In addition, the merits of both broad-based and narrow focused ETFs should be evaluated in the context of cost, liquidity, diversification, performance, and volatility.

The bottom line is that investors can still benefit from significant acquisitions, speculative activity, or company mergers using select ETFs that are positioned to reap the rewards of these circumstances. In addition, the built-in diversification qualities of an ETF help mitigate individual business risks if the end results fail to meet shareholders expectations.

Related Articles
  1. Stock Analysis

    Moderna Therapeutics: An IPO Candidate in 2016?

    Find out the reasons why 2016 may be the year when highly valued biotech company Moderna Therapeutic files for an initial public offering (IPO).
  2. Investing Basics

    Building My Portfolio with BlackRock ETFs and Mutual Funds (ITOT, IXUS)

    Find out how to construct the ideal investment portfolio utilizing BlackRock's tools, resources and its popular low-cost exchange-traded funds (ETFs).
  3. Investing

    3 Things About International Investing and Currency

    As world monetary policy continues to diverge rocking bottom on interest rates while the Fed raises them, expect currencies to continue their bumpy ride.
  4. Stock Analysis

    The Top 5 Micro Cap Biotechnology Stocks for 2016 (BSTC, OSIR)

    Discover some of the most promising micro-cap biotechnology stocks that investors can consider for their 2016 investment portfolio.
  5. Chart Advisor

    These 3 ETFs Suggest Commodities Are Headed Lower (COMT,CCX,DBC)

    The charts of these three exchange traded funds suggest that commodities are stuck in a downtrend and it doesn't look like it will reverse any time soon.
  6. Trading Strategies

    4 ETFs To Trade the Russian Ruble (RSX, ERUS)

    Discover which exchange-traded funds (ETFs) provide investors with the greatest exposure to the Russian ruble and learn about the risks that come with each.
  7. Chart Advisor

    3 Charts That Suggest Now Is The Time To Invest In Real Estate (VNQ, SPG,PSA)

    Real estate assets have some of the strongest uptrends around. We'll take a look at three candidates poised for a move higher.
  8. Stock Analysis

    The Biggest Risks of Investing in Celgene Stock (CELG)

    Discover the biggest risks to investing in Celgene Corporation when reviewing fundamental analysis and other external factors that may affect the stock's price.
  9. Products and Investments

    Are Dividend Stocks a Good Substitute for Bonds?

    Are dividend paying stocks a good substitute for bonds in a low interest rate environment?
  10. Mutual Funds & ETFs

    When Is the Right Time to Change From Mutual Funds to ETFs

    Find out how to determine when it's the right time for you to switch from mutual funds to ETFs, including the benefits of ETFs and who they are best for.
RELATED FAQS
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center